GPT-5 lowers the cost of cell-free protein synthesis
An autonomous lab combining OpenAI’s GPT-5 with Ginkgo Bioworks’ cloud automation cut cell-free protein synthesis costs by 40% through closed-loop experimentation.
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Wow
0
Sad
0
Angry
0
Christopher Holloway
Christopher Holloway is the founder and director of Progressive Robot, a UK-based technology company. A full-stack engineer with more than two decades of experience, he works across PHP development, ecommerce, Linux infrastructure, technical SEO and AI automation, and writes here on technology, AI, hardware and software.
Comments (0)